切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - MST - Inward Rectifier Potassium (Kir) Channels - PC-PLC - Calcium-activated chloride channels (CaCC)

10 件产品

每页
清除全部
  1. XMU-MP-1
    A8735 XMU-MP-1
     2 Citation
    Target: MST
    Summary: MST1/2的强效选择性抑制剂
      ≥41.6 mg/mL
      insoluble in H2O
  2. NPPB
    B6367 NPPB
    Target: Calcium-activated chloride channels (CaCC)|GPR35
    Summary: 氯离子通道抑制剂
      ≥11.05 mg/mL
      insoluble in H2O
  3. U-73122
    B3422 U-73122
     1 Citation
    Target: PC-PLC
    Summary: 磷脂酶C,磷脂酶A2和5-LO(5-脂氧合酶)抑制剂
      ≥5.67 mg/mL
      insoluble in H2O
  4. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  5. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  6. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  7. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  8. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  9. D609
    A3343 D609
    Target: PC-PLC
    Summary: PC-PLC抑制剂
      ≥35.33 mg/mL
      ≥12.7 mg/mL
  10. Glimepiride
    A4033 Glimepiride
    中文名: 格列美脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 磺酰脲类化合物
      ≥21.45 mg/mL
      insoluble in H2O

10 件产品

每页